Prevention: Cycle your use
It is seen across a range of peptides and pharmaceutical compounds that carry ionic or charged components, particularly when those compounds are injected into sensitive or low-fat tissue without adequate buffering
A significant increase in endothelial base-lines, measured by FMD (flow-mediated dilation) were seen over those on the placebo.* The higher curcuminoid supplementation produced a dose-mediated improvement in endothelial function a 37-percent increase measured by FMD
Key Takeaway: Research-grade GHK-Cu is verified by reversed-phase HPLC (purity) and LC-MS (identity), with full documentation provided on a certificate of analysis
The available window for an agonist to produce a measurable increase is compressed, because half the signal is already spent, so a genuine agonist effect can look smaller than it is
Starting with a lower dose and gradually increasing it allows the body to adjust to the medication, reducing the risk of gastrointestinal side effects, which are the most common adverse reactions